Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 176,109 | 741,592 | 657,453 | 575,438 | 505,615 |
| Receivables | 118,990 | 115,749 | 115,458 | 116,545 | 102,357 |
| TOTAL | $317,599 | $866,374 | $780,626 | $698,994 | $617,826 |
| Non-Current Assets | |||||
| PPE Net | 5,876 | 6,015 | 6,288 | 6,660 | 6,964 |
| Intangibles | 4,096 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 275,649 | 282,888 | 313,605 | 334,690 | 350,900 |
| TOTAL | $285,621 | $288,903 | $319,893 | $341,350 | $357,864 |
| Total Assets | $603,220 | $1,155,277 | $1,100,519 | $1,040,344 | $975,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 199,083 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,505 | 118 | 483 | 795 | 317 |
| Accrued Expenses | 99,707 | 20,645 | 21,958 | 23,271 | 19,763 |
| Other current liabilities | N/A | N/A | 19 | 1 | 152 |
| TOTAL | $305,390 | $23,843 | $25,525 | $27,117 | $23,298 |
| Non-Current Liabilities | |||||
| Long Term Debt | 400,000 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 271,898 | 424,582 | 422,616 | 422,164 | 419,509 |
| TOTAL | $644,607 | $424,582 | $422,616 | $422,164 | $419,509 |
| Total Liabilities | $949,997 | $448,425 | $448,141 | $449,281 | $442,807 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,029 | 155,346 | 154,158 | 153,396 | 153,231 |
| Common Shares | 156 | 155 | 154 | 153 | 153 |
| Retained earnings | -1,712,849 | -650,662 | -696,376 | -745,243 | -795,560 |
| Other shareholders' equity | -1,073 | 0 | 0 | 0 | 0 |
| TOTAL | $-346,777 | $706,852 | $652,378 | $591,063 | $532,883 |
| Total Liabilities And Equity | $603,220 | $1,155,277 | $1,100,519 | $1,040,344 | $975,690 |